What Does a Coronary Calcium Score of 0 Mean?

Unpack what a zero coronary calcium score means for your heart’s future. Understand its significance and the nuances of ongoing cardiovascular health.

A coronary calcium score of 0 means that the CT scan found no detectable calcified plaque in your coronary arteries. For most people, this is excellent news: it signals a very low likelihood of a heart attack or cardiovascular death over the next decade or longer. But the result is not a guarantee of perfectly clean arteries, and how much reassurance it provides depends on your age, sex, risk factors, and whether you have symptoms. The score tells a powerful story, but not the whole one.

What the Scan Is Actually Measuring

A coronary artery calcium (CAC) scan uses a non-contrast, ECG-gated CT to look for calcium deposits in the walls of the arteries that supply your heart. The result is expressed as an Agatston score, which combines the area of each calcified spot with a weighting factor based on how dense the deposit is. A lesion has to be at least about one square millimeter and exceed a density threshold of 130 Hounsfield units to register at all. If nothing meets that bar, the score is zero.

The calcium itself is primarily hydroxyapatite, the same mineral found in bone and teeth. It forms as atherosclerotic plaques age and mature. Early plaques contain tiny microcalcifications, smaller than a grain of sand. Over time, these grow into larger fragments and eventually sheet-like deposits visible on CT. The most heavily calcified plaques tend to be stable, while the plaques most responsible for acute heart attacks actually contain less calcium. That paradox is central to understanding both the strengths and limits of a zero score.

How Much Protection Does a Zero Score Offer?

In large, long-term studies, a calcium score of zero is one of the strongest negative risk markers in cardiovascular medicine. A 22-year follow-up of a large cohort found that cardiovascular death rates among people with a zero score were well below 1 event per 1,000 person-years, regardless of whether the person had diabetes or not. All-cause mortality was also low: roughly 1.7 events per 1,000 person-years in women with diabetes and 2.5 in men with diabetes who had a zero score. Among people without diabetes, the numbers were even lower.

A meta-analysis of patients presenting to the emergency department with acute chest pain found that a zero score dropped the relative risk of major adverse cardiac events to about 6% of what it was for patients with any detectable calcium. The rate of death or heart attack in the zero-score group was around 0.5% per year, compared with 3.5% per year in those with scores above zero. That is a massive separation between the two groups, and it holds across different ages and ethnic backgrounds.

How Long Does a Zero Score Stay Reassuring?

Your arteries do not stay static. A zero score today does not mean a zero score five or ten years from now, especially if risk factors like high blood pressure, smoking, or high cholesterol are at work in the background. So researchers have tried to define a “warranty period” for a clean result: how long before you should get rescanned.

A prospective German study following nearly 10,000 asymptomatic, low-to-intermediate risk people found that a zero score carried a warranty period of almost 15 years, with no significant differences by age or sex within that risk group. A more granular analysis from the Multi-Ethnic Study of Atherosclerosis (MESA), which included white, Black, Hispanic, and Chinese-American participants, found that the warranty period before a repeat scan would be likely to find new calcium ranged from about 3 to 7 years depending on sex and race/ethnicity.

The discrepancy between those two estimates largely comes down to methodology and what counts as the endpoint. The MESA analysis used a more conservative threshold, asking how soon a meaningful percentage of people would transition from zero to a non-zero score. The German study tracked actual cardiovascular events. For practical purposes, a zero score in a low-risk person is reassuring for many years, but if you have ongoing risk factors, a check-in at the five-year mark is reasonable.

When a Zero Score Can Be Misleading

Here is where the picture gets more nuanced. A zero calcium score means no calcified plaque was detected. It does not mean no plaque at all. Coronary plaques in their earlier stages can be entirely non-calcified, made up of lipid-rich deposits that do not show up on a standard calcium scan. And these non-calcified plaques are not necessarily harmless.

A systematic review and meta-analysis pooling data from 14 studies and nearly 38,000 patients found that roughly 10% of people with a zero calcium score had non-calcified plaque visible on CT angiography. Of those, about 1.1% had obstructive non-calcified plaque, meaning plaque that significantly narrowed an artery. Another single-center study of 299 patients with zero scores found non-calcified plaque in about 6%, though none of those patients had narrowing greater than 50%.

A larger study of 367 zero-score patients who underwent full CT angiography found atherosclerotic plaque in about 9% of them, and among those with plaque, nearly half had significant blockages above 50%. This matters because it reminds us that the calcium score is a screening tool, not a definitive anatomical map. For asymptomatic people with low-to-intermediate risk, the roughly 1-in-10 chance of having some non-calcified plaque does not change the overall reassuring prognosis much. But for someone with symptoms or strong risk factors, a zero score alone may not be sufficient to rule out trouble.

Zero Scores in the Emergency Department

If you go to the ER with chest pain and get a calcium scan showing a score of zero, the clinical meaning shifts somewhat from the screening context. A large study of over 5,000 patients with acute chest pain found that among those with a zero score, fewer than 5% had any coronary artery disease on follow-up imaging, and only about 0.7% had obstructive disease. The negative predictive value for ruling out the need for a procedure like a stent was over 99%.

In patients whose pre-test probability of heart disease was under 50%, a zero score had a negative predictive value of 95%, meaning it was very effective at identifying people who could safely be sent home without further invasive testing. That said, physicians still use clinical judgment. A zero calcium score in a 35-year-old non-smoker with atypical chest pain carries very different weight than the same score in a 60-year-old smoker with crushing substernal pressure. The score helps refine risk, but it is one input among several.

How a Zero Score Affects Medication Decisions

One of the most direct clinical applications of a zero calcium score is in deciding whether to start a statin. Current expert guidance from the National Lipid Association states that when a person’s calcium score is zero, it is reasonable to hold off on statin therapy and reassess in 5 to 10 years, unless higher-risk conditions are present, including diabetes, a strong family history of premature heart disease, or current smoking. In practice, this helps people who fall in the “borderline” risk category avoid starting a lifelong medication when their actual plaque burden appears to be minimal.

Aspirin for primary prevention is another area where the calcium score shapes the decision. A study using data from the MESA cohort estimated that among people with a zero score, the bleeding risk from daily aspirin outweighed any cardiovascular benefit. The number of people you would need to treat with aspirin to prevent one coronary event was enormous (over 800 in higher-risk individuals and over 2,000 in lower-risk individuals), while the number needed to harm through a major bleed was only around 442. A later analysis confirmed that for people at low or intermediate cardiovascular risk, aspirin resulted in net harm regardless of calcium score, but that a score of zero made the harm-to-benefit ratio especially unfavorable.

The upshot: if your calcium score is zero and you do not have diabetes or another condition that independently raises your risk, you are unlikely to benefit from either a statin or daily aspirin for primary prevention. That is a concrete, practical answer that many people find either relieving or motivating.

Populations Where a Zero Score Deserves Extra Caution

Certain groups can have a zero calcium score and still carry meaningful cardiovascular risk. Familial hypercholesterolemia (FH) is a good example. A study of patients with clinical FH and a history of severely elevated LDL cholesterol found that half had a calcium score of zero, especially those under 45. The absence of calcified plaque in these patients did not mean the absence of disease; it reflected the fact that their plaques had not yet matured enough to calcify. These patients still need aggressive lipid-lowering therapy regardless of the score.

Younger adults in general are more likely to have non-calcified plaques that the scan simply cannot see. The calcification process takes years, so someone developing early atherosclerosis may not show calcium yet. Similarly, case reports have documented rare instances of extensive, multivessel obstructive disease caused entirely by non-calcified plaque in high-risk symptomatic patients with a zero score. These cases are uncommon, but they underline a principle the NLA guidelines make explicit: a zero score should not override the clinical picture if diabetes, heavy smoking, or strong family history is present.

The Behavioral Side of a Clean Result

Getting a zero score is psychologically powerful, and not always in a helpful way. A study of statin adherence and weight-loss behavior found that compliance with prescribed statins was lowest among people who learned they had a zero score, at about 27%. That figure climbed steadily with higher scores: roughly 39% for scores of 1 to 99, 54% for 100 to 399, and 59% for scores of 400 or above. The same gradient appeared for weight loss, with just 20% of zero-score patients making changes compared with about a third of those with high scores.

This makes intuitive sense: a clean scan feels like a clean bill of health, and the urgency to change habits evaporates. But it presents a challenge for physicians. Many of the people who scored zero still had risk factors that warranted attention, like elevated cholesterol, borderline blood pressure, or sedentary lifestyles. The scan provided true information (your arteries look good right now) but in some cases undermined the motivation to keep them that way. A separate study found that health-promoting behaviors did increase over time across all calcium score groups after learning their results, though the moderate-risk group (scores of 101 to 400) showed the strongest shift in how risky they perceived their own health to be.

Is the Scan Worth the Money?

Coronary calcium scans are not always covered by insurance, especially when ordered purely for screening in asymptomatic people. Out-of-pocket costs typically range from $75 to $300 in the United States. The question of whether the scan is cost-effective depends on who is getting it.

An analysis using MESA data found that scanning intermediate-risk patients for calcium and then treating only those with a score of 1 or higher was both more effective and less expensive than treating everyone based on traditional risk calculators alone. Treating only those with scores of 100 or above was also cost-effective when accounting for the downsides of statin use, like side effects and patient reluctance. For people with a family history of coronary disease, a separate cost-effectiveness analysis found that using the calcium score to guide statin decisions was most cost-effective in men, people over 60, and those whose 10-year risk was already at or above 7.5%. Scanning younger or very low-risk individuals was not cost-effective.

Among people with diabetes, a separate analysis found that simply starting everyone on high-intensity statins regardless of their calcium score produced the largest gains in quality-adjusted life years. But when universal statin use was taken off the table, using a calcium score of 100 or higher as the trigger for treatment was cost-effective at around $50,000 per quality-adjusted life year gained, a figure that dropped further if the scan cost less than $75. The economics, in other words, favor scanning people who are in the gray zone, where the score genuinely changes what happens next. Scanning someone at very low risk or someone who would clearly get treated anyway adds cost without adding useful information.

Incidental Findings on the Scan

Because the CT captures a slice of your chest, the radiologist sometimes spots things that have nothing to do with your coronary arteries: lung nodules, thyroid abnormalities, aortic dilation, or other findings in nearby structures. Non-contrast calcium scoring CT produces the fewest of these incidental findings compared with more detailed contrast-enhanced CT scans. Still, they happen, and they can trigger a cascade of follow-up imaging, biopsies, or anxiety that may or may not lead anywhere useful. If you are considering a calcium scan, it is worth knowing that you might end up investigating something unrelated to your heart. Most incidental findings turn out to be benign, but they are a real feature of the experience and one that rarely gets mentioned when people discuss the scan as a simple risk-screening tool.